Literature DB >> 16984408

Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal.

Roland H Stauber1, Uta Rabenhorst, Alexander Rekik, Knut Engels, Carolin Bier, Shirley K Knauer.   

Abstract

Survivin appears to function as a regulator of cell division and as an apoptosis inhibitor in many species. Here, we characterized the nucleocytoplasmic transport of mouse survivin(140), and its splice variants survivin(121) and survivin(40). We show that the dynamic intracellular localization of survivin(140) is mediated by a Crm1-dependent nuclear export signal (NES) present also in survivin(121), but absent in survivin(40). In contrast, neither survivin nor survivin splice variants contain an active nuclear import signal and seem to enter the nucleus by passive diffusion. The activity of the NES is required for survivin-mediated protection against cell death inducing stimuli and influences protein degradation. During mitosis, NES-deficient survivin variants fail to correctly localize to the mitotic machinery and promote proper cell division. In vivo and in vitro protein interaction assays show that survivin(140) and survivin(121) as well as their export-deficient mutants are able to form homo- as well as heterodimers. The trans-dominant negative phenotype observed upon expression of export-deficient survivin appears, therefore, to be mediated by the formation of inactive survivin heterodimers. The survivin-Crm1 axis is essential for the biological activities of murine survivin, and mouse models will allow investigating its functional implications during development and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984408     DOI: 10.1111/j.1600-0854.2006.00486.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  16 in total

1.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 2.  Survivin at a glance.

Authors:  Sally P Wheatley; Dario C Altieri
Journal:  J Cell Sci       Date:  2019-04-04       Impact factor: 5.285

3.  A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K.

Authors:  Iraia García-Santisteban; Igor Arregi; Marián Alonso-Mariño; María A Urbaneja; Juan J Garcia-Vallejo; Sonia Bañuelos; Jose A Rodríguez
Journal:  Cell Mol Life Sci       Date:  2016-06-16       Impact factor: 9.261

4.  Expression of chromosomal regional maintenance protein-1 may be associated with subcellular survivin expression in human gastric and colorectal carcinoma.

Authors:  Michiko Shintani; Akito Tashiro; Akiko Sangawa; Naoki Yamao; Shingo Kamoshida
Journal:  Oncol Lett       Date:  2016-10-04       Impact factor: 2.967

5.  Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity.

Authors:  Haijuan Wang; Michael P Holloway; Li Ma; Zachary A Cooper; Matthew Riolo; Ayman Samkari; Kojo S J Elenitoba-Johnson; Y Eugene Chin; Rachel A Altura
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

6.  Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis.

Authors:  K-S Chan; C-H Wong; Y-F Huang; H-Y Li
Journal:  Cell Death Dis       Date:  2010-07-22       Impact factor: 8.469

7.  XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.

Authors:  Yan Cheng; Michael P Holloway; Kevin Nguyen; Dilara McCauley; Yosef Landesman; Michael G Kauffman; Sharon Shacham; Rachel A Altura
Journal:  Mol Cancer Ther       Date:  2014-01-15       Impact factor: 6.261

8.  Functional analysis of a survivin-like gene in Bombyx mori.

Authors:  Hui Tang; Yu Wu; Haixiang Wu; Yan Wu; Huiling Wu; Wenbing Wang
Journal:  Cytotechnology       Date:  2013-03-26       Impact factor: 2.058

Review 9.  The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis.

Authors:  Mar Carmena; Michael Wheelock; Hironori Funabiki; William C Earnshaw
Journal:  Nat Rev Mol Cell Biol       Date:  2012-12       Impact factor: 94.444

10.  YM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels.

Authors:  Bhavna Kumar; Arti Yadav; James C Lang; Michael J Cipolla; Alessandra C Schmitt; Nicole Arradaza; Theodoros N Teknos; Pawan Kumar
Journal:  Mol Cancer Ther       Date:  2012-06-21       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.